SIMILAR PATTERNS OF AMINO ACIDS FOR 4AGD_A_B49A2000_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h4l CELL DIVISION
PROTEIN KINASE 5


(Homo sapiens)
PF00069
(Pkinase)
6 ALA A  31
LYS A  33
VAL A  64
PHE A  82
CYH A  83
LEU A 133
None
0.57A 4agdA-1h4lA:
16.9
4agdA-1h4lA:
26.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Mus musculus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
6 LEU A 267
ALA A 288
VAL A 318
PHE A 336
GLY A 340
LEU A 389
P16  A   2 ( 4.2A)
P16  A   2 (-3.4A)
P16  A   2 ( 4.7A)
P16  A   2 ( 4.4A)
P16  A   2 (-3.4A)
P16  A   2 (-4.4A)
0.35A 4agdA-1opkA:
29.8
4agdA-1opkA:
28.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 616
ALA A 642
LYS A 644
VAL A 675
CYH A 694
GLY A 697
LEU A 818
CYH A 828
None
0.65A 4agdA-1rjbA:
41.1
4agdA-1rjbA:
47.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LYS A 644
VAL A 675
GLY A 697
LEU A 818
CYH A 828
PHE A 830
None
1.26A 4agdA-1rjbA:
41.1
4agdA-1rjbA:
47.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  78
ALA A  99
LYS A 101
GLY A 153
LEU A 201
CYH A 211
ATP  A 535 (-3.9A)
ATP  A 535 (-3.6A)
ATP  A 535 ( 2.5A)
ATP  A 535 ( 4.7A)
ATP  A 535 (-4.8A)
ATP  A 535 ( 4.5A)
1.01A 4agdA-1s9iA:
21.0
4agdA-1s9iA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  78
ALA A  99
VAL A 131
GLY A 153
LEU A 201
CYH A 211
ATP  A 535 (-3.9A)
ATP  A 535 (-3.6A)
5EA  A1001 (-4.5A)
ATP  A 535 ( 4.7A)
ATP  A 535 (-4.8A)
ATP  A 535 ( 4.5A)
0.84A 4agdA-1s9iA:
21.0
4agdA-1s9iA:
25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1snx TYROSINE-PROTEIN
KINASE ITK/TSK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 389
VAL A 419
PHE A 437
GLY A 441
LEU A 489
None
0.51A 4agdA-1snxA:
29.7
4agdA-1snxA:
32.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 595
ALA A 621
LYS A 623
VAL A 654
CYH A 673
GLY A 676
LEU A 799
CYH A 809
PHE A 811
STI  A   3 ( 3.8A)
STI  A   3 (-3.5A)
STI  A   3 (-3.7A)
STI  A   3 (-4.3A)
STI  A   3 (-4.5A)
STI  A   3 ( 3.8A)
STI  A   3 (-4.4A)
STI  A   3 (-4.5A)
STI  A   3 (-3.6A)
0.65A 4agdA-1t46A:
33.3
4agdA-1t46A:
49.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 344
ALA A 367
VAL A 399
GLY A 420
LEU A 468
STU  A 100 (-3.8A)
STU  A 100 (-3.2A)
None
STU  A 100 (-3.5A)
STU  A 100 (-4.5A)
0.41A 4agdA-1u59A:
30.5
4agdA-1u59A:
30.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1


(Homo sapiens)
PF00069
(Pkinase)
7 LEU A  15
ALA A  36
LYS A  38
VAL A  68
CYH A  87
GLY A  90
LEU A 137
HYM  A 400 (-4.2A)
HYM  A 400 (-3.5A)
HYM  A 400 (-3.2A)
HYM  A 400 (-4.8A)
HYM  A 400 (-4.2A)
None
HYM  A 400 (-4.5A)
0.58A 4agdA-1zltA:
20.3
4agdA-1zltA:
23.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU X  17
ALA X  37
VAL X  67
GLY X  88
LEU X 137
STU  X 902 (-3.8A)
STU  X 902 (-3.1A)
None
STU  X 902 (-3.5A)
STU  X 902 (-4.4A)
0.40A 4agdA-2dq7X:
30.4
4agdA-2dq7X:
32.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hck HEMATOPOETIC CELL
KINASE HCK


(Homo sapiens)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
6 LEU A 273
ALA A 293
VAL A 323
PHE A 340
GLY A 344
LEU A 393
QUE  A   1 (-3.9A)
QUE  A   1 (-3.5A)
None
QUE  A   1 (-4.2A)
QUE  A   1 (-3.0A)
QUE  A   1 (-4.4A)
0.58A 4agdA-2hckA:
27.8
4agdA-2hckA:
30.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 251
ALA A 271
VAL A 301
PHE A 318
GLY A 322
LEU A 371
1BM  A 499 ( 3.7A)
1BM  A 499 (-3.6A)
None
1BM  A 499 (-4.1A)
1BM  A 499 (-3.5A)
1BM  A 499 (-4.4A)
0.63A 4agdA-2hk5A:
29.9
4agdA-2hk5A:
35.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hw6 MAP
KINASE-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
5 LEU A  55
ALA A  76
GLY A 130
LEU A 177
CYH A 190
None
0.39A 4agdA-2hw6A:
19.9
4agdA-2hw6A:
24.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 269
LYS A 271
VAL A 299
GLY A 321
LEU A 370
PHE A 382
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-4.6A)
None
GIN  A 600 (-4.7A)
GIN  A 600 (-4.0A)
0.80A 4agdA-2hz0A:
30.7
4agdA-2hz0A:
35.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 269
VAL A 299
PHE A 317
GLY A 321
LEU A 370
PHE A 382
GIN  A 600 (-3.1A)
GIN  A 600 (-4.6A)
GIN  A 600 (-4.3A)
None
GIN  A 600 (-4.7A)
GIN  A 600 (-4.0A)
0.65A 4agdA-2hz0A:
30.7
4agdA-2hz0A:
35.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 248
ALA A 269
LYS A 271
VAL A 299
GLY A 321
LEU A 370
GIN  A 600 ( 4.6A)
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-4.6A)
None
GIN  A 600 (-4.7A)
0.62A 4agdA-2hz0A:
30.7
4agdA-2hz0A:
35.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 248
ALA A 269
VAL A 299
PHE A 317
GLY A 321
LEU A 370
GIN  A 600 ( 4.6A)
GIN  A 600 (-3.1A)
GIN  A 600 (-4.6A)
GIN  A 600 (-4.3A)
None
GIN  A 600 (-4.7A)
0.47A 4agdA-2hz0A:
30.7
4agdA-2hz0A:
35.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1


(Gallus gallus)
PF00373
(FERM_M)
PF07714
(Pkinase_Tyr)
5 ALA A 452
VAL A 484
CYH A 502
GLY A 505
LEU A 553
4ST  A1687 (-3.3A)
None
4ST  A1687 (-4.1A)
4ST  A1687 (-3.2A)
4ST  A1687 (-4.4A)
0.53A 4agdA-2j0jA:
32.5
4agdA-2j0jA:
22.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2jkm FOCAL ADHESION
KINASE 1


(Gallus gallus)
PF07714
(Pkinase_Tyr)
6 ALA A 452
LYS A 454
VAL A 484
CYH A 502
GLY A 505
LEU A 553
BII  A1687 (-3.5A)
BII  A1687 (-2.9A)
None
BII  A1687 (-4.1A)
BII  A1687 (-3.6A)
BII  A1687 (-4.2A)
0.64A 4agdA-2jkmA:
31.3
4agdA-2jkmA:
31.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 588
ALA A 614
LYS A 616
VAL A 647
CYH A 666
GLY A 669
LEU A 785
None
0.48A 4agdA-2ogvA:
27.4
4agdA-2ogvA:
48.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70


(Homo sapiens)
PF00017
(SH2)
PF07714
(Pkinase_Tyr)
6 LEU A 344
ALA A 367
LYS A 369
VAL A 399
GLY A 420
LEU A 468
ANP  A 615 (-4.4A)
ANP  A 615 (-3.3A)
ANP  A 615 (-3.1A)
None
ANP  A 615 ( 3.9A)
ANP  A 615 (-4.7A)
0.87A 4agdA-2ozoA:
22.4
4agdA-2ozoA:
23.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psq FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 487
ALA A 515
LYS A 517
VAL A 564
GLY A 570
LEU A 633
None
0.48A 4agdA-2psqA:
34.3
4agdA-2psqA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7r RIBOSOMAL PROTEIN S6
KINASE ALPHA-1


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  68
ALA A  92
VAL A 125
PHE A 143
GLY A 147
LEU A 194
STU  A   1 (-3.8A)
STU  A   1 (-3.3A)
None
STU  A   1 (-4.6A)
STU  A   1 ( 3.9A)
STU  A   1 (-4.6A)
0.47A 4agdA-2z7rA:
16.1
4agdA-2z7rA:
27.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A1002
ALA A1028
LYS A1030
VAL A1060
GLY A1082
S91  A   1 ( 4.1A)
S91  A   1 (-3.2A)
S91  A   1 ( 4.2A)
None
S91  A   1 (-3.3A)
0.55A 4agdA-2z8cA:
29.4
4agdA-2z8cA:
36.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2zv7 TYROSINE-PROTEIN
KINASE LYN


(Mus musculus)
PF07714
(Pkinase_Tyr)
7 LEU A 253
ALA A 273
LYS A 275
VAL A 303
PHE A 321
GLY A 325
LEU A 374
None
0.83A 4agdA-2zv7A:
29.9
4agdA-2zv7A:
34.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 487
ALA A 515
LYS A 517
VAL A 564
GLY A 570
LEU A 633
M33  A1996 (-4.0A)
M33  A1996 (-3.3A)
M33  A1996 ( 4.5A)
None
M33  A1996 ( 4.8A)
M33  A1996 (-4.5A)
0.63A 4agdA-3b2tA:
33.6
4agdA-3b2tA:
49.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 484
ALA A 512
VAL A 561
GLY A 567
LEU A 630
PHE A 489
C4F  A   1 ( 3.9A)
C4F  A   1 (-3.3A)
C4F  A   1 ( 4.8A)
None
C4F  A   1 (-4.6A)
C4F  A   1 (-3.7A)
0.78A 4agdA-3c4fA:
33.5
4agdA-3c4fA:
54.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dko EPHRIN TYPE-A
RECEPTOR 7


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM)
6 ALA A 663
VAL A 695
PHE A 713
GLY A 717
LEU A 765
PHE A 777
IHZ  A1001 (-3.3A)
IHZ  A1001 ( 4.9A)
None
IHZ  A1001 ( 3.9A)
IHZ  A1001 (-4.6A)
IHZ  A1001 (-4.7A)
0.61A 4agdA-3dkoA:
31.1
4agdA-3dkoA:
33.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3fzp PROTEIN TYROSINE
KINASE 2 BETA


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 431
ALA A 455
LYS A 457
VAL A 487
GLY A 508
LEU A 556
AGS  A 999 ( 4.4A)
AGS  A 999 (-3.6A)
AGS  A 999 (-2.5A)
None
None
AGS  A 999 (-4.5A)
0.80A 4agdA-3fzpA:
30.5
4agdA-3fzpA:
32.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 833
ALA A 859
LYS A 861
VAL A 892
VAL A 909
CYH A 912
LEU A1029
CYH A1039
PHE A1041
8ST  A2001 ( 4.7A)
8ST  A2001 ( 3.8A)
8ST  A2001 (-4.0A)
8ST  A2001 ( 4.7A)
8ST  A2001 (-4.1A)
8ST  A2001 (-3.8A)
None
8ST  A2001 (-4.2A)
8ST  A2001 ( 3.7A)
0.68A 4agdA-3hngA:
41.4
4agdA-3hngA:
67.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 833
ALA A 859
VAL A 892
VAL A 909
CYH A 912
GLY A 915
LEU A1029
CYH A1039
PHE A1041
8ST  A2001 ( 4.7A)
8ST  A2001 ( 3.8A)
8ST  A2001 ( 4.7A)
8ST  A2001 (-4.1A)
8ST  A2001 (-3.8A)
None
None
8ST  A2001 (-4.2A)
8ST  A2001 ( 3.7A)
0.60A 4agdA-3hngA:
41.4
4agdA-3hngA:
67.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mi9 CELL DIVISION
PROTEIN KINASE 9


(Homo sapiens)
PF00069
(Pkinase)
6 ALA A  46
LYS A  48
VAL A  79
PHE A 105
CYH A 106
LEU A 156
None
0.62A 4agdA-3mi9A:
21.4
4agdA-3mi9A:
25.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nyo G PROTEIN-COUPLED
RECEPTOR KINASE 6


(Homo sapiens)
PF00069
(Pkinase)
PF00615
(RGS)
5 LEU A 192
ALA A 213
VAL A 247
GLY A 269
LEU A 318
AMP  A 577 ( 4.3A)
AMP  A 577 (-3.4A)
None
None
AMP  A 577 (-4.8A)
0.52A 4agdA-3nyoA:
20.9
4agdA-3nyoA:
22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q4t ACTIVIN RECEPTOR
TYPE-2A


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 217
LYS A 219
PHE A 269
GLY A 273
LEU A 329
TAK  A   2 (-3.5A)
TAK  A   2 (-2.9A)
TAK  A   2 (-4.3A)
TAK  A   2 (-3.6A)
TAK  A   2 (-4.6A)
0.53A 4agdA-3q4tA:
23.4
4agdA-3q4tA:
24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q5i PROTEIN KINASE

(Plasmodium
berghei)
PF00069
(Pkinase)
PF13499
(EF-hand_7)
5 LEU A  63
ALA A  84
PHE A 146
GLY A 150
LEU A 197
ANP  A1634 ( 4.3A)
ANP  A1634 (-3.6A)
ANP  A1634 (-4.8A)
None
ANP  A1634 (-4.4A)
0.55A 4agdA-3q5iA:
19.2
4agdA-3q5iA:
22.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3sxs CYTOPLASMIC
TYROSINE-PROTEIN
KINASE BMX


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 423
ALA A 443
VAL A 473
GLY A 495
LEU A 543
PP2  A   1 (-4.1A)
PP2  A   1 (-3.2A)
None
PP2  A   1 ( 4.2A)
PP2  A   1 (-4.6A)
0.47A 4agdA-3sxsA:
29.0
4agdA-3sxsA:
32.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 484
ALA A 512
VAL A 561
GLY A 567
LEU A 630
07J  A   1 ( 4.3A)
07J  A   1 (-3.5A)
07J  A   1 (-4.7A)
07J  A   1 (-3.7A)
07J  A   1 ( 4.4A)
0.51A 4agdA-3tt0A:
34.6
4agdA-3tt0A:
50.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3v5q NT-3 GROWTH FACTOR
RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 544
ALA A 570
VAL A 601
GLY A 623
LEU A 686
0F4  A 902 ( 4.2A)
0F4  A 902 (-3.2A)
None
0F4  A 902 (-3.4A)
0F4  A 902 (-4.5A)
0.52A 4agdA-3v5qA:
26.6
4agdA-3v5qA:
32.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 840
ALA A 866
VAL A 899
VAL A 916
PHE A 918
CYH A 919
GLY A 922
LEU A1035
CYH A1045
4TT  A2001 ( 4.0A)
4TT  A2001 (-3.5A)
None
None
4TT  A2001 (-4.5A)
4TT  A2001 (-4.3A)
4TT  A2001 (-3.7A)
4TT  A2001 (-4.8A)
None
0.37A 4agdA-3vidA:
38.8
4agdA-3vidA:
85.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wig DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  75
ALA A  96
LYS A  98
GLY A 150
LEU A 198
CYH A 208
ANP  A 401 (-3.8A)
ANP  A 401 (-3.2A)
ANP  A 401 (-2.7A)
ANP  A 401 ( 4.3A)
ANP  A 401 (-4.8A)
CHU  A 403 ( 3.7A)
1.29A 4agdA-3wigA:
16.1
4agdA-3wigA:
22.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
9 LEU A 840
ALA A 866
VAL A 899
VAL A 916
PHE A 918
CYH A 919
GLY A 922
LEU A1035
CYH A1045
LEV  A1201 ( 3.8A)
LEV  A1201 (-3.5A)
None
LEV  A1201 ( 4.6A)
LEV  A1201 (-4.7A)
LEV  A1201 (-4.1A)
LEV  A1201 (-3.6A)
LEV  A1201 (-4.8A)
GOL  A1210 ( 3.3A)
0.33A 4agdA-3wzdA:
37.6
4agdA-3wzdA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4agu CYCLIN-DEPENDENT
KINASE-LIKE 1


(Homo sapiens)
PF00069
(Pkinase)
6 ALA A  31
LYS A  33
VAL A  64
CYH A  83
LEU A 133
CYH A 143
D15  A 500 (-3.4A)
D15  A 500 ( 4.1A)
None
D15  A 500 (-4.3A)
D15  A 500 (-4.5A)
D15  A 500 ( 4.0A)
0.61A 4agdA-4aguA:
22.0
4agdA-4aguA:
25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw5 EPHRIN TYPE-B
RECEPTOR 4


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 121
LYS A 123
PHE A 171
GLY A 175
LEU A 223
30K  A1365 (-3.2A)
30K  A1365 (-3.8A)
30K  A1365 (-4.4A)
30K  A1365 (-3.5A)
30K  A1365 (-4.5A)
0.54A 4agdA-4aw5A:
26.3
4agdA-4aw5A:
29.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bc6 SERINE/THREONINE-PRO
TEIN KINASE 10


(Homo sapiens)
PF00069
(Pkinase)
7 LEU A  42
ALA A  63
VAL A  94
PHE A 112
CYH A 113
GLY A 116
LEU A 164
XZN  A1317 (-3.6A)
XZN  A1317 (-3.5A)
XZN  A1317 (-4.4A)
XZN  A1317 (-4.5A)
XZN  A1317 (-3.7A)
XZN  A1317 ( 3.7A)
XZN  A1317 (-4.7A)
0.70A 4agdA-4bc6A:
19.9
4agdA-4bc6A:
25.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
5 LEU A 663
ALA A 684
VAL A 721
GLY A 743
LEU A 789
AGS  A1985 (-4.2A)
AGS  A1985 (-3.5A)
None
None
AGS  A1985 (-4.8A)
0.43A 4agdA-4crsA:
19.9
4agdA-4crsA:
23.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eut SERINE/THREONINE-PRO
TEIN KINASE TBK1


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  15
ALA A  36
VAL A  68
PHE A  88
CYH A  89
GLY A  92
BX7  A 401 (-3.7A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.5A)
0.40A 4agdA-4eutA:
12.0
4agdA-4eutA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  15
ALA A  36
VAL A  68
PHE A  88
CYH A  89
GLY A  92
BX7  A 401 (-3.9A)
BX7  A 401 (-3.4A)
None
BX7  A 401 ( 4.6A)
BX7  A 401 (-4.1A)
BX7  A 401 (-3.3A)
0.41A 4agdA-4euuA:
21.2
4agdA-4euuA:
24.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4f4p TYROSINE-PROTEIN
KINASE SYK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 377
ALA A 400
LYS A 402
VAL A 433
GLY A 454
LEU A 501
0SB  A 701 ( 3.9A)
0SB  A 701 (-3.3A)
0SB  A 701 ( 4.8A)
None
0SB  A 701 (-3.5A)
0SB  A 701 (-4.4A)
0.83A 4agdA-4f4pA:
29.4
4agdA-4f4pA:
34.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fie SERINE/THREONINE-PRO
TEIN KINASE PAK 4


(Homo sapiens)
PF00069
(Pkinase)
PF00786
(PBD)
6 ALA A 348
LYS A 350
VAL A 379
PHE A 397
GLY A 401
LEU A 447
ANP  A1001 (-3.6A)
ANP  A1001 (-3.0A)
None
ANP  A1001 ( 4.6A)
None
ANP  A1001 (-4.7A)
0.72A 4agdA-4fieA:
20.7
4agdA-4fieA:
25.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fl3 TYROSINE-PROTEIN
KINASE SYK


(Homo sapiens)
PF00017
(SH2)
PF07714
(Pkinase_Tyr)
5 LEU A 377
ALA A 400
VAL A 433
GLY A 454
LEU A 501
ANP  A 701 ( 4.6A)
ANP  A 701 (-3.3A)
ANP  A 701 (-4.8A)
ANP  A 701 ( 4.2A)
ANP  A 701 (-4.5A)
0.49A 4agdA-4fl3A:
28.5
4agdA-4fl3A:
23.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fod ALK TYROSINE KINASE
RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A1122
ALA A1148
LYS A1150
VAL A1180
GLY A1202
LEU A1256
0UV  A1501 (-3.8A)
0UV  A1501 (-3.4A)
0UV  A1501 (-3.7A)
0UV  A1501 ( 4.9A)
0UV  A1501 (-3.6A)
0UV  A1501 (-4.6A)
0.74A 4agdA-4fodA:
29.7
4agdA-4fodA:
33.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fr4 SERINE/THREONINE-PRO
TEIN KINASE 32A


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  50
VAL A  84
VAL A 100
GLY A 106
LEU A 153
STU  A 401 (-3.2A)
None
None
STU  A 401 ( 3.7A)
STU  A 401 (-4.7A)
0.41A 4agdA-4fr4A:
20.2
4agdA-4fr4A:
23.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hvi TYROSINE-PROTEIN
KINASE JAK3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 828
ALA A 853
VAL A 884
GLY A 908
LEU A 956
19S  A1201 (-3.9A)
19S  A1201 (-3.3A)
None
19S  A1201 ( 3.8A)
19S  A1201 (-4.5A)
0.42A 4agdA-4hviA:
29.2
4agdA-4hviA:
31.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A 406
ALA A 427
VAL A 453
GLY A 475
LEU A 522
CYH A 533
T28  A 701 (-3.8A)
T28  A 701 (-3.0A)
None
T28  A 701 ( 3.0A)
T28  A 701 (-3.9A)
T28  A 701 (-3.7A)
0.80A 4agdA-4idtA:
21.2
4agdA-4idtA:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jlc SERINE/THREONINE-PRO
TEIN KINASE TBK1


(Mus musculus)
PF00069
(Pkinase)
6 LEU A  15
ALA A  36
VAL A  68
PHE A  88
CYH A  89
GLY A  92
SU6  A 701 (-3.6A)
SU6  A 701 (-3.4A)
None
SU6  A 701 (-4.0A)
SU6  A 701 (-3.8A)
SU6  A 701 (-3.8A)
0.42A 4agdA-4jlcA:
17.9
4agdA-4jlcA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jxf SERINE/THREONINE-PRO
TEIN KINASE PLK4


(Homo sapiens)
PF00069
(Pkinase)
5 LEU A  18
ALA A  39
CYH A  92
GLY A  95
LEU A 143
631  A 301 (-3.4A)
631  A 301 (-3.3A)
631  A 301 (-4.5A)
631  A 301 ( 3.7A)
631  A 301 (-4.0A)
0.38A 4agdA-4jxfA:
18.1
4agdA-4jxfA:
23.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 478
ALA A 506
VAL A 555
GLY A 561
LEU A 624
ACP  A 801 (-3.8A)
ACP  A 801 (-3.3A)
ACP  A 801 (-4.7A)
ACP  A 801 ( 4.6A)
ACP  A 801 (-4.4A)
0.49A 4agdA-4k33A:
34.2
4agdA-4k33A:
51.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ks8 SERINE/THREONINE-PRO
TEIN KINASE PAK 6


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 434
VAL A 465
PHE A 483
GLY A 487
LEU A 533
B49  A 701 (-3.2A)
None
B49  A 701 (-4.3A)
B49  A 701 ( 3.7A)
B49  A 701 (-4.5A)
0.43A 4agdA-4ks8A:
21.9
4agdA-4ks8A:
27.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l01 TYROSINE-PROTEIN
KINASE JAK1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 589
LYS A 622
VAL A 651
PHE A 669
GLY A 673
LEU A 721
None
0.77A 4agdA-4l01A:
26.0
4agdA-4l01A:
24.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lgg PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC


(Gallus gallus)
PF07714
(Pkinase_Tyr)
6 LEU A 273
ALA A 293
LYS A 295
VAL A 323
GLY A 344
LEU A 393
VGG  A 601 (-3.2A)
VGG  A 601 (-3.5A)
VGG  A 601 (-3.8A)
VGG  A 601 ( 4.8A)
VGG  A 601 ( 3.2A)
VGG  A 601 (-4.5A)
0.83A 4agdA-4lggA:
27.6
4agdA-4lggA:
34.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o38 CYCLIN-G-ASSOCIATED
KINASE


(Homo sapiens)
PF00069
(Pkinase)
8 LEU A  46
ALA A  67
LYS A  69
VAL A  99
CYH A 126
GLY A 128
LEU A 180
CYH A 190
SIN  A 401 ( 3.9A)
SIN  A 401 ( 3.7A)
None
None
SIN  A 401 (-4.3A)
SIN  A 401 (-3.5A)
SIN  A 401 ( 4.5A)
None
0.82A 4agdA-4o38A:
19.8
4agdA-4o38A:
24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oav PROTEIN (RNASE L)

(Homo sapiens)
PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
PF12796
(Ank_2)
PF13857
(Ank_5)
5 ALA B 390
VAL B 418
VAL B 434
CYH B 437
LEU B 492
ACP  B 801 (-3.2A)
None
ACP  B 801 (-4.8A)
ACP  B 801 (-4.5A)
ACP  B 801 (-4.5A)
0.55A 4agdA-4oavB:
17.0
4agdA-4oavB:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4otd SERINE/THREONINE-PRO
TEIN KINASE N1


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
5 LEU A 627
ALA A 648
VAL A 685
GLY A 707
LEU A 753
None
0.47A 4agdA-4otdA:
20.9
4agdA-4otdA:
26.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 616
ALA A 642
VAL A 675
CYH A 694
GLY A 697
LEU A 818
CYH A 828
PHE A 830
P30  A1001 (-3.8A)
P30  A1001 (-3.4A)
None
None
P30  A1001 (-3.4A)
P30  A1001 (-4.6A)
P30  A1001 (-4.1A)
P30  A1001 (-3.9A)
0.36A 4agdA-4rt7A:
32.8
4agdA-4rt7A:
43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LYS A 644
VAL A 675
GLY A 697
LEU A 818
CYH A 828
PHE A 830
P30  A1001 (-3.4A)
None
P30  A1001 (-3.4A)
P30  A1001 (-4.6A)
P30  A1001 (-4.1A)
P30  A1001 (-3.9A)
0.66A 4agdA-4rt7A:
32.8
4agdA-4rt7A:
43.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ueu TYROSINE KINASE AS -
A COMMON ANCESTOR OF
SRC AND ABL


(synthetic
construct)
PF07714
(Pkinase_Tyr)
6 LEU A  14
ALA A  35
LYS A  37
VAL A  65
GLY A  87
LEU A 136
ACP  A1264 ( 4.5A)
ACP  A1264 (-2.9A)
None
None
ACP  A1264 (-3.5A)
ACP  A1264 ( 4.8A)
0.77A 4agdA-4ueuA:
30.2
4agdA-4ueuA:
37.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4usf STE20-LIKE
SERINE/THREONINE-PRO
TEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
6 ALA A  61
VAL A  92
PHE A 110
CYH A 111
GLY A 114
LEU A 162
6UI  A 700 (-3.3A)
None
6UI  A 700 (-4.3A)
6UI  A 700 (-4.2A)
6UI  A 700 ( 4.2A)
6UI  A 700 (-4.2A)
0.64A 4agdA-4usfA:
21.6
4agdA-4usfA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4usf STE20-LIKE
SERINE/THREONINE-PRO
TEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  40
ALA A  61
LYS A  63
PHE A 110
GLY A 114
LEU A 162
6UI  A 700 ( 4.9A)
6UI  A 700 (-3.3A)
6UI  A 700 (-4.5A)
6UI  A 700 (-4.3A)
6UI  A 700 ( 4.2A)
6UI  A 700 (-4.2A)
1.02A 4agdA-4usfA:
21.6
4agdA-4usfA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4usf STE20-LIKE
SERINE/THREONINE-PRO
TEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
6 LEU A  40
ALA A  61
PHE A 110
CYH A 111
GLY A 114
LEU A 162
6UI  A 700 ( 4.9A)
6UI  A 700 (-3.3A)
6UI  A 700 (-4.3A)
6UI  A 700 (-4.2A)
6UI  A 700 ( 4.2A)
6UI  A 700 (-4.2A)
0.70A 4agdA-4usfA:
21.6
4agdA-4usfA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wbo RHODOPSIN KINASE

(Bos taurus)
PF00069
(Pkinase)
PF00615
(RGS)
6 LEU A 193
ALA A 214
LYS A 216
VAL A 248
GLY A 270
LEU A 321
ANW  A 601 ( 4.0A)
ANW  A 601 (-3.4A)
None
None
ANW  A 601 ( 4.5A)
ANW  A 601 (-4.9A)
0.76A 4agdA-4wboA:
16.8
4agdA-4wboA:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wsq AP2-ASSOCIATED
PROTEIN KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
8 LEU A  52
ALA A  72
VAL A 104
PHE A 128
CYH A 129
GLY A 132
LEU A 183
CYH A 193
KSA  A 405 ( 4.0A)
KSA  A 405 (-3.2A)
None
KSA  A 405 (-4.8A)
KSA  A 405 (-4.5A)
KSA  A 405 (-3.5A)
KSA  A 405 (-4.6A)
KSA  A 405 (-3.4A)
0.49A 4agdA-4wsqA:
22.1
4agdA-4wsqA:
24.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xey TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
no annotation 6 LEU B 267
ALA B 288
LYS B 290
PHE B 336
GLY B 340
LEU B 389
1N1  B 601 (-3.7A)
1N1  B 601 (-3.5A)
1N1  B 601 (-4.6A)
1N1  B 601 ( 4.2A)
1N1  B 601 (-3.5A)
1N1  B 601 (-4.3A)
0.68A 4agdA-4xeyB:
30.9
4agdA-4xeyB:
32.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xey TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
no annotation 6 LEU B 267
ALA B 288
VAL B 318
PHE B 336
GLY B 340
LEU B 389
1N1  B 601 (-3.7A)
1N1  B 601 (-3.5A)
1N1  B 601 ( 4.3A)
1N1  B 601 ( 4.2A)
1N1  B 601 (-3.5A)
1N1  B 601 (-4.3A)
0.56A 4agdA-4xeyB:
30.9
4agdA-4xeyB:
32.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 616
ALA A 642
VAL A 675
CYH A 694
GLY A 697
LEU A 818
CYH A 828
PHE A 830
P30  A1001 (-4.0A)
P30  A1001 (-3.5A)
None
P30  A1001 (-4.2A)
P30  A1001 (-3.5A)
P30  A1001 (-4.3A)
P30  A1001 (-4.8A)
P30  A1001 ( 4.1A)
0.45A 4agdA-4xufA:
29.0
4agdA-4xufA:
51.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y93 NON-SPECIFIC
PROTEIN-TYROSINE
KINASE,NON-SPECIFIC
PROTEIN-TYROSINE
KINASE


(Bos taurus)
PF00169
(PH)
PF00779
(BTK)
PF07714
(Pkinase_Tyr)
6 LEU A 408
ALA A 428
LYS A 430
VAL A 458
GLY A 480
LEU A 528
746  A 702 (-3.8A)
746  A 702 (-2.4A)
746  A 702 (-3.7A)
None
746  A 702 (-3.6A)
746  A 702 (-4.4A)
0.71A 4agdA-4y93A:
29.2
4agdA-4y93A:
27.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5a46 FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 LEU A 484
ALA A 512
LYS A 514
VAL A 561
GLY A 567
LEU A 630
38O  A1769 (-3.2A)
38O  A1769 (-3.6A)
38O  A1769 ( 3.1A)
38O  A1769 (-4.3A)
38O  A1769 (-3.4A)
38O  A1769 (-4.6A)
0.49A 4agdA-5a46A:
34.7
4agdA-5a46A:
45.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ci7 SERINE/THREONINE-PRO
TEIN KINASE ULK1


(Homo sapiens)
PF00069
(Pkinase)
6 ALA A  44
LYS A  46
VAL A  76
CYH A  95
GLY A  98
LEU A 145
51W  A 401 (-3.4A)
GOL  A 404 ( 3.1A)
None
51W  A 401 (-3.9A)
51W  A 401 (-3.7A)
51W  A 401 (-4.5A)
0.55A 4agdA-5ci7A:
22.8
4agdA-5ci7A:
26.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e8y TGF-BETA RECEPTOR
TYPE-2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 275
LYS A 277
PHE A 327
GLY A 331
LEU A 386
CYH A 396
STU  A 601 (-3.1A)
STU  A 601 (-2.4A)
STU  A 601 (-3.4A)
STU  A 601 (-3.5A)
STU  A 601 (-3.9A)
STU  A 601 (-3.2A)
0.77A 4agdA-5e8yA:
18.8
4agdA-5e8yA:
27.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eyk AURORA KINASE B-A

(Xenopus laevis)
PF00069
(Pkinase)
6 LEU A  99
ALA A 120
LYS A 122
PHE A 172
GLY A 176
LEU A 223
5U5  A 401 (-3.8A)
5U5  A 401 (-3.5A)
5U5  A 401 (-2.6A)
5U5  A 401 (-4.5A)
5U5  A 401 (-3.4A)
5U5  A 401 (-4.7A)
0.48A 4agdA-5eykA:
21.8
4agdA-5eykA:
25.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fm2 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 730
ALA A 756
VAL A 804
GLY A 810
LEU A 881
PP1  A2012 (-4.6A)
PP1  A2012 (-3.2A)
PP1  A2012 (-4.5A)
PTR  A 809 (-2.4A)
PP1  A2012 (-4.6A)
0.52A 4agdA-5fm2A:
32.3
4agdA-5fm2A:
41.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5grn PLATELET-DERIVED
GROWTH FACTOR
RECEPTOR ALPHA


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 LEU A 599
ALA A 625
VAL A 658
CYH A 677
GLY A 680
LEU A 825
CYH A 835
PHE A 837
748  A1001 (-3.8A)
748  A1001 (-3.7A)
748  A1001 ( 4.8A)
748  A1001 (-4.5A)
748  A1001 ( 4.0A)
748  A1001 (-4.3A)
748  A1001 (-4.5A)
748  A1001 (-3.7A)
0.46A 4agdA-5grnA:
41.0
4agdA-5grnA:
48.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5grn PLATELET-DERIVED
GROWTH FACTOR
RECEPTOR ALPHA


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 LEU A 599
LYS A 627
VAL A 658
GLY A 680
LEU A 825
CYH A 835
PHE A 837
748  A1001 (-3.8A)
748  A1001 (-4.0A)
748  A1001 ( 4.8A)
748  A1001 ( 4.0A)
748  A1001 (-4.3A)
748  A1001 (-4.5A)
748  A1001 (-3.7A)
0.63A 4agdA-5grnA:
41.0
4agdA-5grnA:
48.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i3o BMP-2-INDUCIBLE
PROTEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
7 LEU A  57
ALA A  77
VAL A 109
CYH A 133
GLY A 136
LEU A 187
CYH A 197
IDV  A 401 (-3.8A)
IDV  A 401 (-3.6A)
None
IDV  A 401 (-4.6A)
IDV  A 401 (-3.4A)
IDV  A 401 (-4.4A)
IDV  A 401 (-3.6A)
0.63A 4agdA-5i3oA:
21.8
4agdA-5i3oA:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3


(Homo sapiens)
PF00069
(Pkinase)
6 ALA A  43
VAL A  74
PHE A  92
CYH A  93
GLY A  96
LEU A 143
6G2  A 901 (-3.2A)
None
6G2  A 901 (-4.1A)
TPO  A 145 (-4.1A)
6G2  A 901 (-3.6A)
6G2  A 901 (-4.7A)
0.29A 4agdA-5j5tA:
20.1
4agdA-5j5tA:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jzn SERINE/THREONINE-PRO
TEIN KINASE DCLK1


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 417
LYS A 419
VAL A 449
GLY A 471
LEU A 518
GUI  A 701 ( 3.9A)
GUI  A 701 (-3.1A)
None
GUI  A 701 (-3.6A)
GUI  A 701 (-4.4A)
0.53A 4agdA-5jznA:
21.3
4agdA-5jznA:
25.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l2r FUMARATE HYDRATASE

(Leishmania
major)
PF05681
(Fumerase)
PF05683
(Fumerase_C)
6 LEU A 489
ALA A 551
VAL A 389
VAL A 411
PHE A 549
LEU A 391
None
1.01A 4agdA-5l2rA:
undetectable
4agdA-5l2rA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lpy PROTEIN
BRASSINOSTEROID
INSENSITIVE 1


(Arabidopsis
thaliana)
PF00069
(Pkinase)
6 ALA A 909
LYS A 911
VAL A 940
PHE A 958
GLY A 962
LEU A1016
ATP  A1200 (-3.5A)
ATP  A1200 (-3.8A)
None
ATP  A1200 ( 4.0A)
ATP  A1200 ( 4.0A)
ATP  A1200 (-4.6A)
0.71A 4agdA-5lpyA:
21.9
4agdA-5lpyA:
27.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lpz PROTEIN
BRASSINOSTEROID
INSENSITIVE 1


(Arabidopsis
thaliana)
PF00069
(Pkinase)
6 ALA A 909
LYS A 911
VAL A 940
PHE A 958
GLY A 962
LEU A1016
ADP  A1200 (-3.5A)
ADP  A1200 ( 4.3A)
None
ADP  A1200 (-4.1A)
ADP  A1200 ( 4.0A)
ADP  A1200 (-4.7A)
0.69A 4agdA-5lpzA:
21.8
4agdA-5lpzA:
26.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ncl SERINE/THREONINE-PRO
TEIN KINASE CBK1


(Saccharomyces
cerevisiae)
no annotation 6 ALA A 379
LYS A 381
VAL A 413
PHE A 431
GLY A 435
LEU A 482
ANP  A 801 ( 3.9A)
ANP  A 801 (-2.6A)
ANP  A 801 ( 4.9A)
ANP  A 801 ( 4.9A)
None
ANP  A 801 (-4.8A)
0.73A 4agdA-5nclA:
17.8
4agdA-5nclA:
15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vef SERINE/THREONINE-PRO
TEIN KINASE PAK 4


(Homo sapiens)
no annotation 5 ALA A 348
VAL A 379
PHE A 397
GLY A 401
LEU A 447
M77  A 601 ( 3.5A)
None
M77  A 601 (-4.1A)
M77  A 601 ( 4.8A)
M77  A 601 (-4.6A)
0.49A 4agdA-5vefA:
21.3
4agdA-5vefA:
26.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vil MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 5


(Homo sapiens)
no annotation 5 LEU A 686
ALA A 707
VAL A 738
GLY A 760
LEU A 810
9E1  A1001 (-3.7A)
9E1  A1001 (-3.5A)
9E1  A1001 (-4.1A)
9E1  A1001 (-3.4A)
9E1  A1001 (-4.5A)
0.53A 4agdA-5vilA:
15.1
4agdA-5vilA:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vo1 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 12


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 150
PHE A 192
CYH A 193
GLY A 196
LEU A 243
9FS  A 501 (-3.4A)
9FS  A 501 (-4.3A)
9FS  A 501 (-4.3A)
9FS  A 501 (-3.6A)
9FS  A 501 (-4.7A)
0.46A 4agdA-5vo1A:
23.8
4agdA-5vo1A:
27.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5win -

(-)
no annotation 6 LEU A 551
LYS A 581
VAL A 610
PHE A 628
GLY A 632
LEU A 680
SKE  A 901 (-3.4A)
SKE  A 901 ( 4.7A)
SKE  A 901 ( 4.7A)
SKE  A 901 (-3.6A)
SKE  A 901 (-3.1A)
SKE  A 901 (-4.1A)
0.68A 4agdA-5winA:
26.3
4agdA-5winA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xzw SERINE/THREONINE-PRO
TEIN KINASE RAD53


(Saccharomyces
cerevisiae)
no annotation 5 ALA A 225
VAL A 257
PHE A 275
GLY A 279
LEU A 326
None
0.55A 4agdA-5xzwA:
18.6
4agdA-5xzwA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ao5 SERINE/THREONINE-PRO
TEIN KINASE 3


(Homo sapiens)
no annotation 6 LEU A  33
ALA A  54
VAL A  83
CYH A 102
GLY A 105
LEU A 153
ANP  A 501 ( 3.8A)
ANP  A 501 ( 3.7A)
None
ANP  A 501 (-4.2A)
ANP  A 501 ( 4.0A)
ANP  A 501 (-4.6A)
0.56A 4agdA-6ao5A:
21.0
4agdA-6ao5A:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c7y TYROSINE-PROTEIN
KINASE JAK1


(Homo sapiens)
no annotation 6 LEU A 881
ALA A 906
VAL A 938
PHE A 958
GLY A 962
LEU A1010
ADP  A1201 ( 4.5A)
ADP  A1201 (-3.4A)
None
None
ADP  A1201 ( 4.1A)
ADP  A1201 (-4.5A)
0.55A 4agdA-6c7yA:
27.0
4agdA-6c7yA:
13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fdy -

(-)
no annotation 7 LEU U  20
ALA U  42
VAL U  75
PHE U  93
CYH U  94
GLY U  97
LEU U 144
DB8  U 301 (-3.7A)
DB8  U 301 (-3.6A)
DB8  U 301 (-4.8A)
DB8  U 301 ( 4.4A)
DB8  U 301 (-4.2A)
DB8  U 301 ( 4.1A)
DB8  U 301 (-4.8A)
0.76A 4agdA-6fdyU:
20.0
4agdA-6fdyU:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fek PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET


(Homo sapiens)
no annotation 5 LEU A 730
ALA A 756
VAL A 804
GLY A 810
LEU A 881
ADN  A1104 ( 4.0A)
ADN  A1104 (-3.4A)
ADN  A1104 ( 4.6A)
ADN  A1104 ( 3.8A)
ADN  A1104 (-4.3A)
0.41A 4agdA-6fekA:
31.7
4agdA-6fekA:
23.72